Mankind Pharma Limited has announced the completion of its acquisition of Bharat Serums and Vaccines Limited (BSV) for a massive INR 13,768 Crore. This strategic acquisition, finalized on October 23, 2024, is set to bolster Mankind’s presence in the women’s health and fertility market, positioning it as a leader in the sector. The acquisition, undertaken […]
AstraZeneca Pharma India Limited (AstraZeneca India) and Mankind Pharma Limited have embarked on a strategic collaboration for the exclusive distribution of AstraZeneca’s asthma medication, Symbicort (budesonide and formoterol fumarate dihydrate combination). This partnership aims to leverage Mankind Pharma’s expansive distribution network to enhance the accessibility and effectiveness of asthma treatment across India, a country contributing […]
Panacea Biotec said that its fully-owned subsidiary Biotec Pharma Ltd. (PBPL) has agreed to sell its domestic formulations brands for India and Nepal to Mankind Pharma for INR 1,872 crores. According to Panacea Biotec, its consolidated revenue is INR 634.78 crores and the domestic formulations brands that are part of the deal had revenue from […]